Key result
Calcium-channel antagonists may slow the development and progression of atherosclerosis.
Why the study?
Do calcium-channel antagonists prevent the development and progression of atherosclerosis?
Do calcium-channel antagonists prevent the development and progression of atherosclerosis?
This review suggests calcium-channel antagonists may slow atherosclerosis progression, though evidence is primarily from patients with established disease.
No takes yet. Share an insight, caveat, or question.
May support secondary prevention strategies; leaves open dedicated primary prevention trials.
Borcherding et al. (1993) conducted a review in Atherosclerosis. Calcium-channel antagonists was evaluated. Calcium-channel antagonists may retard the development and progression of atherosclerosis based on animal and human clinical trials.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: